Trimetazidine - A new aetiology for extrapyramidal disorders: A case of parkinsonism and akathisia [8];La trimétazidine - Nouvelle étiologie de troubles extrapyramidaux: Un cas de syndrome parkinsonien avec akathisie

Therapie

Volumn 60, Issue 6, 2005, Pages 603-605

  Masmoudi, Kamel ^a   Gras Champel, Valérie ^a   Douadi, Youssef ^b   Massen, Henri ^a   Andréjak, Michel ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b CENTRE HOSPITALIER   (France)

Author keywords

Akathisia; Extrapyramidal disorders; Parkinsonism; Restless legs syndrom; Trimetazidine

Indexed keywords

BENAZEPRIL; FOSINOPRIL; HYDROCHLOROTHIAZIDE; TRIMETAZIDINE; VASODILATOR AGENT;

ADULT; AKATHISIA; CASE REPORT; EXTRAPYRAMIDAL SYNDROME; HUMAN; LETTER; MALE; PARKINSONISM; PRIORITY JOURNAL; CHEMICALLY INDUCED DISORDER; HYPERTENSION; MIDDLE AGED; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PATHOPHYSIOLOGY; RESTLESS LEGS SYNDROME;

AKATHISIA, DRUG-INDUCED; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PARKINSON DISEASE, SECONDARY; RESTLESS LEGS SYNDROME; TRIMETAZIDINE; VASODILATOR AGENTS;

EID: 33645768997     PISSN: 00405957     EISSN: 00405957     Source Type: Journal    
DOI: 10.2515/therapie:2005090     Document Type: Letter

References (10)

1. Masmoudi K, Gras-Champel V, Lemaire-Hurtel AS, et al. Troubles extra-pyramidaux sous véralipride (Agréal®), traitement symptomatique des bouffées de chaleur : à propos de 17 cas. Rev Med Interne 2005; 26: 453-7
2. Nguyen N, Pradel V, Micallef J, et al. Les syndromes parkinsoniens médicamenteux. Therapie 2004; 59: 105-12
3. Marti-Masso JF. Parkinsonismo por trimetazidina. Neurologia 2004; 19: 392-5
4. Sommet A, Azais-Vuillemin C, Bagheri H, et al. Trimetazidine: a new cause for drug-induced parkinsonism? Mov Disord 2005; 20: 1080-1
5. Begaud B, Evreux JC, Jouglard J, et al. Imputabilité des effets inattendus ou toxiques des médicaments : actualisation de la méthode utilisée en France. Therapie 1995; 40: 111-8
6. Marti-Masso JF, Marti I, Carrera N, et al. Trimetazidine induced parkinsonism gait disorders and tremor. Therapie 2005; 60: 419-22
7. Mena MA, Garcia de Yebenes MJ, Tabernero C, et al. Effects of calcium antagonists on the dopamine system. Clin Neuropharmacol 1995; 18: 410-26
8. Brucke T, Wober C, Podreka I, et al. D2 receptor blockade by fluarizine and cinnarizine explains extrapyramidal side effects. A SPECT study. J Cereb Blood Flow Metab 1995; 15: 513-8
9. Negrotti A, Calzetti S. A long-term follow-up study of cinnarizinne- and flunarizine-induced parkinsonism. Mov Disord 1997; 12: 107-10
10. Teive HA, Troiano AR, Germiniani FM, et al. Flunarizine and cinnarizine-induced parkinsonism: a historical and clinical analysis. Parkinsonism Relat Disord 2004; 10: 243-5